Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour
2016 ◽
Vol 61
◽
pp. 94-101
◽
2018 ◽
Vol 53
(10-11)
◽
pp. 1328-1334
◽
Keyword(s):
Keyword(s):